Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
72 participants
INTERVENTIONAL
2024-11-02
2025-04-05
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effect of Toy-Type Nebulizer on Fear and Anxiety in Children Receiving Inhaler Treatment
NCT05213013
Inhalation Therapy and Therapeutic Play
NCT06197646
The Effect of Therapeutic Play Applied by Using Toy Nebulizer and Toy Mask on Child's Fear and Anxiety Level
NCT05415566
The Effect of Distraction Methods Used During Inhalation Therapy on Children's Fear and Anxiety
NCT06510166
Use Of Pet Therapy In Chıldren Receıvıng Nebulızer Treatment
NCT07082907
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
The control group
5 minutes before starting the inhaler treatment, the child's anxiety level should be determined, and the child's emotional state should be evaluated by two observers.
After washing hands, the aerosol medication ordered by the physician should be applied using a nebulizer mask.
In the 5th minute after the inhaler treatment begins, the child's anxiety level should be determined, and the child's emotional state should be evaluated by two observers.
5 minutes after the inhaler treatment ends, the child's anxiety level should be determined, and the child's emotional state should be evaluated by two observers.
No interventions assigned to this group
The intervention group
5 minutes before starting the inhaler treatment, the child's anxiety level should be determined, and the child's emotional state should be evaluated by two observers.
After washing hands, the aerosol medication ordered by the physician should be applied using a nebulizer mask.
The child is introduced to the plush toy of Kral Şakir, a character they recognize from cartoons. After explaining that King Şakir also needs help to recover, the nebulizer mask is applied to the toy, and saline solution is added to the mask's reservoir. Then, the treatment is started together with the child.
In the 5th minute after the inhaler treatment begins, the child's anxiety level should be determined, and the child's emotional state should be evaluated by two observers.
5 minutes after the inhaler treatment ends, the child's anxiety level should be determined, and the child's emotional state should be evaluated by two observers.
using toy during inhaler treatment
The mask application on the toy will be performed only during the first inhaler treatment that the children receive in the emergency department.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
using toy during inhaler treatment
The mask application on the toy will be performed only during the first inhaler treatment that the children receive in the emergency department.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* The child being scheduled to receive their first inhaler treatment after admission to the unit,
* No IV or IM interventions being performed before the inhaler treatment,
* The child and parents being willing to participate in the study,
* No mental or neurological disabilities present in the child or parent,
* The child not having any life-threatening illnesses,
* The child having an oxygen saturation of 95% or higher,
* The child's body temperature not exceeding 37.5 degrees Celsius,
* The child's cognitive level and motor development being appropriate for their age,
* The child being able to count up to 10,
* The parent being literate,
* No visual or auditory problems present in the child or parent
Exclusion Criteria
* The parent or child wanting to withdraw from the study at any stage of the research.
4 Years
6 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Bakirkoy Dr. Sadi Konuk Research and Training Hospital
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ayse Boke
Principal Investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Bakirkoy Dr Sadi Konuk Researching and Training Hospital
Istanbul, Istanbul, Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
BakırköySadiKonuk-aboke-01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.